Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global iPSC Cell Therapies Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Preclinical/Research Stage
1.2.3 Clinical Stage
1.2.4 Commercial Stage
1.3 Market by Application
1.3.1 Global iPSC Cell Therapies Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global iPSC Cell Therapies Market Perspective (2021–2032)
2.2 Global iPSC Cell Therapies Growth Trends by Region
2.2.1 Global iPSC Cell Therapies Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 iPSC Cell Therapies Historic Market Size by Region (2021–2026)
2.2.3 iPSC Cell Therapies Forecasted Market Size by Region (2027–2032)
2.3 iPSC Cell Therapies Market Dynamics
2.3.1 iPSC Cell Therapies Industry Trends
2.3.2 iPSC Cell Therapies Market Drivers
2.3.3 iPSC Cell Therapies Market Challenges
2.3.4 iPSC Cell Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top iPSC Cell Therapies Players by Revenue
3.1.1 Global Top iPSC Cell Therapies Players by Revenue (2021–2026)
3.1.2 Global iPSC Cell Therapies Revenue Market Share by Players (2021–2026)
3.2 Global Top iPSC Cell Therapies Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by iPSC Cell Therapies Revenue
3.4 Global iPSC Cell Therapies Market Concentration Ratio
3.4.1 Global iPSC Cell Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by iPSC Cell Therapies Revenue in 2025
3.5 Global Key Players of iPSC Cell Therapies Head Offices and Areas Served
3.6 Global Key Players of iPSC Cell Therapies, Products and Applications
3.7 Global Key Players of iPSC Cell Therapies, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 iPSC Cell Therapies Breakdown Data by Type
4.1 Global iPSC Cell Therapies Historic Market Size by Type (2021–2026)
4.2 Global iPSC Cell Therapies Forecasted Market Size by Type (2027–2032)
5 iPSC Cell Therapies Breakdown Data by Application
5.1 Global iPSC Cell Therapies Historic Market Size by Application (2021–2026)
5.2 Global iPSC Cell Therapies Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America iPSC Cell Therapies Market Size (2021–2032)
6.2 North America iPSC Cell Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America iPSC Cell Therapies Market Size by Country (2021–2026)
6.4 North America iPSC Cell Therapies Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe iPSC Cell Therapies Market Size (2021–2032)
7.2 Europe iPSC Cell Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe iPSC Cell Therapies Market Size by Country (2021–2026)
7.4 Europe iPSC Cell Therapies Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific iPSC Cell Therapies Market Size (2021–2032)
8.2 Asia-Pacific iPSC Cell Therapies Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific iPSC Cell Therapies Market Size by Region (2021–2026)
8.4 Asia-Pacific iPSC Cell Therapies Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America iPSC Cell Therapies Market Size (2021–2032)
9.2 Latin America iPSC Cell Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America iPSC Cell Therapies Market Size by Country (2021–2026)
9.4 Latin America iPSC Cell Therapies Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa iPSC Cell Therapies Market Size (2021–2032)
10.2 Middle East & Africa iPSC Cell Therapies Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa iPSC Cell Therapies Market Size by Country (2021–2026)
10.4 Middle East & Africa iPSC Cell Therapies Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer(BlueRock Therapeutics)
11.1.1 Bayer(BlueRock Therapeutics) Company Details
11.1.2 Bayer(BlueRock Therapeutics) Business Overview
11.1.3 Bayer(BlueRock Therapeutics) iPSC Cell Therapies Introduction
11.1.4 Bayer(BlueRock Therapeutics) Revenue in iPSC Cell Therapies Business (2021–2026)
11.1.5 Bayer(BlueRock Therapeutics) Recent Development
11.2 Notch Therapeutics
11.2.1 Notch Therapeutics Company Details
11.2.2 Notch Therapeutics Business Overview
11.2.3 Notch Therapeutics iPSC Cell Therapies Introduction
11.2.4 Notch Therapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.2.5 Notch Therapeutics Recent Development
11.3 Evotec Group
11.3.1 Evotec Group Company Details
11.3.2 Evotec Group Business Overview
11.3.3 Evotec Group iPSC Cell Therapies Introduction
11.3.4 Evotec Group Revenue in iPSC Cell Therapies Business (2021–2026)
11.3.5 Evotec Group Recent Development
11.4 Pluristyx, Inc
11.4.1 Pluristyx, Inc Company Details
11.4.2 Pluristyx, Inc Business Overview
11.4.3 Pluristyx, Inc iPSC Cell Therapies Introduction
11.4.4 Pluristyx, Inc Revenue in iPSC Cell Therapies Business (2021–2026)
11.4.5 Pluristyx, Inc Recent Development
11.5 Cellino
11.5.1 Cellino Company Details
11.5.2 Cellino Business Overview
11.5.3 Cellino iPSC Cell Therapies Introduction
11.5.4 Cellino Revenue in iPSC Cell Therapies Business (2021–2026)
11.5.5 Cellino Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Details
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics iPSC Cell Therapies Introduction
11.6.4 Fate Therapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.6.5 Fate Therapeutics Recent Development
11.7 Allogene Therapeutics, Inc.
11.7.1 Allogene Therapeutics, Inc. Company Details
11.7.2 Allogene Therapeutics, Inc. Business Overview
11.7.3 Allogene Therapeutics, Inc. iPSC Cell Therapies Introduction
11.7.4 Allogene Therapeutics, Inc. Revenue in iPSC Cell Therapies Business (2021–2026)
11.7.5 Allogene Therapeutics, Inc. Recent Development
11.8 Takeda Pharmaceutical Company Limited
11.8.1 Takeda Pharmaceutical Company Limited Company Details
11.8.2 Takeda Pharmaceutical Company Limited Business Overview
11.8.3 Takeda Pharmaceutical Company Limited iPSC Cell Therapies Introduction
11.8.4 Takeda Pharmaceutical Company Limited Revenue in iPSC Cell Therapies Business (2021–2026)
11.8.5 Takeda Pharmaceutical Company Limited Recent Development
11.9 Century Therapeutics
11.9.1 Century Therapeutics Company Details
11.9.2 Century Therapeutics Business Overview
11.9.3 Century Therapeutics iPSC Cell Therapies Introduction
11.9.4 Century Therapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.9.5 Century Therapeutics Recent Development
11.10 Resolution Therapeutics
11.10.1 Resolution Therapeutics Company Details
11.10.2 Resolution Therapeutics Business Overview
11.10.3 Resolution Therapeutics iPSC Cell Therapies Introduction
11.10.4 Resolution Therapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.10.5 Resolution Therapeutics Recent Development
11.11 Kenai
11.11.1 Kenai Company Details
11.11.2 Kenai Business Overview
11.11.3 Kenai iPSC Cell Therapies Introduction
11.11.4 Kenai Revenue in iPSC Cell Therapies Business (2021–2026)
11.11.5 Kenai Recent Development
11.12 Garuda Therapeutics
11.12.1 Garuda Therapeutics Company Details
11.12.2 Garuda Therapeutics Business Overview
11.12.3 Garuda Therapeutics iPSC Cell Therapies Introduction
11.12.4 Garuda Therapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.12.5 Garuda Therapeutics Recent Development
11.13 Hebecell
11.13.1 Hebecell Company Details
11.13.2 Hebecell Business Overview
11.13.3 Hebecell iPSC Cell Therapies Introduction
11.13.4 Hebecell Revenue in iPSC Cell Therapies Business (2021–2026)
11.13.5 Hebecell Recent Development
11.14 Allele Biotechnology and Pharmaceuticals
11.14.1 Allele Biotechnology and Pharmaceuticals Company Details
11.14.2 Allele Biotechnology and Pharmaceuticals Business Overview
11.14.3 Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Introduction
11.14.4 Allele Biotechnology and Pharmaceuticals Revenue in iPSC Cell Therapies Business (2021–2026)
11.14.5 Allele Biotechnology and Pharmaceuticals Recent Development
11.15 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
11.15.1 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Company Details
11.15.2 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Business Overview
11.15.3 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Introduction
11.15.4 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Revenue in iPSC Cell Therapies Business (2021–2026)
11.15.5 Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Recent Development
11.16 ElevateBio
11.16.1 ElevateBio Company Details
11.16.2 ElevateBio Business Overview
11.16.3 ElevateBio iPSC Cell Therapies Introduction
11.16.4 ElevateBio Revenue in iPSC Cell Therapies Business (2021–2026)
11.16.5 ElevateBio Recent Development
11.17 iCamumo
11.17.1 iCamumo Company Details
11.17.2 iCamumo Business Overview
11.17.3 iCamumo iPSC Cell Therapies Introduction
11.17.4 iCamumo Revenue in iPSC Cell Therapies Business (2021–2026)
11.17.5 iCamumo Recent Development
11.18 BeiGene, Ltd
11.18.1 BeiGene, Ltd Company Details
11.18.2 BeiGene, Ltd Business Overview
11.18.3 BeiGene, Ltd iPSC Cell Therapies Introduction
11.18.4 BeiGene, Ltd Revenue in iPSC Cell Therapies Business (2021–2026)
11.18.5 BeiGene, Ltd Recent Development
11.19 LumiSTAR Biotechnology
11.19.1 LumiSTAR Biotechnology Company Details
11.19.2 LumiSTAR Biotechnology Business Overview
11.19.3 LumiSTAR Biotechnology iPSC Cell Therapies Introduction
11.19.4 LumiSTAR Biotechnology Revenue in iPSC Cell Therapies Business (2021–2026)
11.19.5 LumiSTAR Biotechnology Recent Development
11.20 Neukio Biotherapeutics
11.20.1 Neukio Biotherapeutics Company Details
11.20.2 Neukio Biotherapeutics Business Overview
11.20.3 Neukio Biotherapeutics iPSC Cell Therapies Introduction
11.20.4 Neukio Biotherapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.20.5 Neukio Biotherapeutics Recent Development
11.21 Help Therapeutics
11.21.1 Help Therapeutics Company Details
11.21.2 Help Therapeutics Business Overview
11.21.3 Help Therapeutics iPSC Cell Therapies Introduction
11.21.4 Help Therapeutics Revenue in iPSC Cell Therapies Business (2021–2026)
11.21.5 Help Therapeutics Recent Development
11.22 Hopstem Biotechnology Inc.
11.22.1 Hopstem Biotechnology Inc. Company Details
11.22.2 Hopstem Biotechnology Inc. Business Overview
11.22.3 Hopstem Biotechnology Inc. iPSC Cell Therapies Introduction
11.22.4 Hopstem Biotechnology Inc. Revenue in iPSC Cell Therapies Business (2021–2026)
11.22.5 Hopstem Biotechnology Inc. Recent Development
11.23 Nuwacell Biotechnologies Co., Ltd.
11.23.1 Nuwacell Biotechnologies Co., Ltd. Company Details
11.23.2 Nuwacell Biotechnologies Co., Ltd. Business Overview
11.23.3 Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Introduction
11.23.4 Nuwacell Biotechnologies Co., Ltd. Revenue in iPSC Cell Therapies Business (2021–2026)
11.23.5 Nuwacell Biotechnologies Co., Ltd. Recent Development
11.24 ihan Biotech
11.24.1 ihan Biotech Company Details
11.24.2 ihan Biotech Business Overview
11.24.3 ihan Biotech iPSC Cell Therapies Introduction
11.24.4 ihan Biotech Revenue in iPSC Cell Therapies Business (2021–2026)
11.24.5 ihan Biotech Recent Development
11.25 iRegene
11.25.1 iRegene Company Details
11.25.2 iRegene Business Overview
11.25.3 iRegene iPSC Cell Therapies Introduction
11.25.4 iRegene Revenue in iPSC Cell Therapies Business (2021–2026)
11.25.5 iRegene Recent Development
11.26 Allife Medicine
11.26.1 Allife Medicine Company Details
11.26.2 Allife Medicine Business Overview
11.26.3 Allife Medicine iPSC Cell Therapies Introduction
11.26.4 Allife Medicine Revenue in iPSC Cell Therapies Business (2021–2026)
11.26.5 Allife Medicine Recent Development
11.27 CellOrigin
11.27.1 CellOrigin Company Details
11.27.2 CellOrigin Business Overview
11.27.3 CellOrigin iPSC Cell Therapies Introduction
11.27.4 CellOrigin Revenue in iPSC Cell Therapies Business (2021–2026)
11.27.5 CellOrigin Recent Development
11.28 XellSmart bio
11.28.1 XellSmart bio Company Details
11.28.2 XellSmart bio Business Overview
11.28.3 XellSmart bio iPSC Cell Therapies Introduction
11.28.4 XellSmart bio Revenue in iPSC Cell Therapies Business (2021–2026)
11.28.5 XellSmart bio Recent Development
11.29 ThinkingBioMed
11.29.1 ThinkingBioMed Company Details
11.29.2 ThinkingBioMed Business Overview
11.29.3 ThinkingBioMed iPSC Cell Therapies Introduction
11.29.4 ThinkingBioMed Revenue in iPSC Cell Therapies Business (2021–2026)
11.29.5 ThinkingBioMed Recent Development
11.30 Cell Inspire Bio
11.30.1 Cell Inspire Bio Company Details
11.30.2 Cell Inspire Bio Business Overview
11.30.3 Cell Inspire Bio iPSC Cell Therapies Introduction
11.30.4 Cell Inspire Bio Revenue in iPSC Cell Therapies Business (2021–2026)
11.30.5 Cell Inspire Bio Recent Development
11.31 Hema Cell
11.31.1 Hema Cell Company Details
11.31.2 Hema Cell Business Overview
11.31.3 Hema Cell iPSC Cell Therapies Introduction
11.31.4 Hema Cell Revenue in iPSC Cell Therapies Business (2021–2026)
11.31.5 Hema Cell Recent Development
11.32 Yuesai BIO
11.32.1 Yuesai BIO Company Details
11.32.2 Yuesai BIO Business Overview
11.32.3 Yuesai BIO iPSC Cell Therapies Introduction
11.32.4 Yuesai BIO Revenue in iPSC Cell Therapies Business (2021–2026)
11.32.5 Yuesai BIO Recent Development
11.33 Cytovia
11.33.1 Cytovia Company Details
11.33.2 Cytovia Business Overview
11.33.3 Cytovia iPSC Cell Therapies Introduction
11.33.4 Cytovia Revenue in iPSC Cell Therapies Business (2021–2026)
11.33.5 Cytovia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global iPSC Cell Therapies Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Preclinical/Research Stage
Table 3. Key Players of Clinical Stage
Table 4. Key Players of Commercial Stage
Table 5. Global iPSC Cell Therapies Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global iPSC Cell Therapies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global iPSC Cell Therapies Market Size by Region (US$ Million), 2021–2026
Table 8. Global iPSC Cell Therapies Market Share by Region (2021–2026)
Table 9. Global iPSC Cell Therapies Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global iPSC Cell Therapies Market Share by Region (2027–2032)
Table 11. iPSC Cell Therapies Market Trends
Table 12. iPSC Cell Therapies Market Drivers
Table 13. iPSC Cell Therapies Market Challenges
Table 14. iPSC Cell Therapies Market Restraints
Table 15. Global iPSC Cell Therapies Revenue by Players (US$ Million), 2021–2026
Table 16. Global iPSC Cell Therapies Market Share by Players (2021–2026)
Table 17. Global Top iPSC Cell Therapies Players by Tier (Tier 1, Tier 2, and Tier 3), based on iPSC Cell Therapies Revenue, 2025
Table 18. Ranking of Global Top iPSC Cell Therapies Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by iPSC Cell Therapies Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of iPSC Cell Therapies, Headquarters and Area Served
Table 21. Global Key Players of iPSC Cell Therapies, Products and Applications
Table 22. Global Key Players of iPSC Cell Therapies, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global iPSC Cell Therapies Market Size by Type (US$ Million), 2021–2026
Table 25. Global iPSC Cell Therapies Revenue Market Share by Type (2021–2026)
Table 26. Global iPSC Cell Therapies Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global iPSC Cell Therapies Revenue Market Share by Type (2027–2032)
Table 28. Global iPSC Cell Therapies Market Size by Application (US$ Million), 2021–2026
Table 29. Global iPSC Cell Therapies Revenue Market Share by Application (2021–2026)
Table 30. Global iPSC Cell Therapies Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global iPSC Cell Therapies Revenue Market Share by Application (2027–2032)
Table 32. North America iPSC Cell Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America iPSC Cell Therapies Market Size by Country (US$ Million), 2021–2026
Table 34. North America iPSC Cell Therapies Market Size by Country (US$ Million), 2027–2032
Table 35. Europe iPSC Cell Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe iPSC Cell Therapies Market Size by Country (US$ Million), 2021–2026
Table 37. Europe iPSC Cell Therapies Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific iPSC Cell Therapies Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific iPSC Cell Therapies Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific iPSC Cell Therapies Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America iPSC Cell Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America iPSC Cell Therapies Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America iPSC Cell Therapies Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa iPSC Cell Therapies Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa iPSC Cell Therapies Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa iPSC Cell Therapies Market Size by Country (US$ Million), 2027–2032
Table 47. Bayer(BlueRock Therapeutics) Company Details
Table 48. Bayer(BlueRock Therapeutics) Business Overview
Table 49. Bayer(BlueRock Therapeutics) iPSC Cell Therapies Product
Table 50. Bayer(BlueRock Therapeutics) Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 51. Bayer(BlueRock Therapeutics) Recent Development
Table 52. Notch Therapeutics Company Details
Table 53. Notch Therapeutics Business Overview
Table 54. Notch Therapeutics iPSC Cell Therapies Product
Table 55. Notch Therapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 56. Notch Therapeutics Recent Development
Table 57. Evotec Group Company Details
Table 58. Evotec Group Business Overview
Table 59. Evotec Group iPSC Cell Therapies Product
Table 60. Evotec Group Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 61. Evotec Group Recent Development
Table 62. Pluristyx, Inc Company Details
Table 63. Pluristyx, Inc Business Overview
Table 64. Pluristyx, Inc iPSC Cell Therapies Product
Table 65. Pluristyx, Inc Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 66. Pluristyx, Inc Recent Development
Table 67. Cellino Company Details
Table 68. Cellino Business Overview
Table 69. Cellino iPSC Cell Therapies Product
Table 70. Cellino Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 71. Cellino Recent Development
Table 72. Fate Therapeutics Company Details
Table 73. Fate Therapeutics Business Overview
Table 74. Fate Therapeutics iPSC Cell Therapies Product
Table 75. Fate Therapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 76. Fate Therapeutics Recent Development
Table 77. Allogene Therapeutics, Inc. Company Details
Table 78. Allogene Therapeutics, Inc. Business Overview
Table 79. Allogene Therapeutics, Inc. iPSC Cell Therapies Product
Table 80. Allogene Therapeutics, Inc. Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 81. Allogene Therapeutics, Inc. Recent Development
Table 82. Takeda Pharmaceutical Company Limited Company Details
Table 83. Takeda Pharmaceutical Company Limited Business Overview
Table 84. Takeda Pharmaceutical Company Limited iPSC Cell Therapies Product
Table 85. Takeda Pharmaceutical Company Limited Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 86. Takeda Pharmaceutical Company Limited Recent Development
Table 87. Century Therapeutics Company Details
Table 88. Century Therapeutics Business Overview
Table 89. Century Therapeutics iPSC Cell Therapies Product
Table 90. Century Therapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 91. Century Therapeutics Recent Development
Table 92. Resolution Therapeutics Company Details
Table 93. Resolution Therapeutics Business Overview
Table 94. Resolution Therapeutics iPSC Cell Therapies Product
Table 95. Resolution Therapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 96. Resolution Therapeutics Recent Development
Table 97. Kenai Company Details
Table 98. Kenai Business Overview
Table 99. Kenai iPSC Cell Therapies Product
Table 100. Kenai Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 101. Kenai Recent Development
Table 102. Garuda Therapeutics Company Details
Table 103. Garuda Therapeutics Business Overview
Table 104. Garuda Therapeutics iPSC Cell Therapies Product
Table 105. Garuda Therapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 106. Garuda Therapeutics Recent Development
Table 107. Hebecell Company Details
Table 108. Hebecell Business Overview
Table 109. Hebecell iPSC Cell Therapies Product
Table 110. Hebecell Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 111. Hebecell Recent Development
Table 112. Allele Biotechnology and Pharmaceuticals Company Details
Table 113. Allele Biotechnology and Pharmaceuticals Business Overview
Table 114. Allele Biotechnology and Pharmaceuticals iPSC Cell Therapies Product
Table 115. Allele Biotechnology and Pharmaceuticals Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 116. Allele Biotechnology and Pharmaceuticals Recent Development
Table 117. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Company Details
Table 118. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Business Overview
Table 119. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us iPSC Cell Therapies Product
Table 120. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 121. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Recent Development
Table 122. ElevateBio Company Details
Table 123. ElevateBio Business Overview
Table 124. ElevateBio iPSC Cell Therapies Product
Table 125. ElevateBio Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 126. ElevateBio Recent Development
Table 127. iCamumo Company Details
Table 128. iCamumo Business Overview
Table 129. iCamumo iPSC Cell Therapies Product
Table 130. iCamumo Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 131. iCamumo Recent Development
Table 132. BeiGene, Ltd Company Details
Table 133. BeiGene, Ltd Business Overview
Table 134. BeiGene, Ltd iPSC Cell Therapies Product
Table 135. BeiGene, Ltd Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 136. BeiGene, Ltd Recent Development
Table 137. LumiSTAR Biotechnology Company Details
Table 138. LumiSTAR Biotechnology Business Overview
Table 139. LumiSTAR Biotechnology iPSC Cell Therapies Product
Table 140. LumiSTAR Biotechnology Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 141. LumiSTAR Biotechnology Recent Development
Table 142. Neukio Biotherapeutics Company Details
Table 143. Neukio Biotherapeutics Business Overview
Table 144. Neukio Biotherapeutics iPSC Cell Therapies Product
Table 145. Neukio Biotherapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 146. Neukio Biotherapeutics Recent Development
Table 147. Help Therapeutics Company Details
Table 148. Help Therapeutics Business Overview
Table 149. Help Therapeutics iPSC Cell Therapies Product
Table 150. Help Therapeutics Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 151. Help Therapeutics Recent Development
Table 152. Hopstem Biotechnology Inc. Company Details
Table 153. Hopstem Biotechnology Inc. Business Overview
Table 154. Hopstem Biotechnology Inc. iPSC Cell Therapies Product
Table 155. Hopstem Biotechnology Inc. Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 156. Hopstem Biotechnology Inc. Recent Development
Table 157. Nuwacell Biotechnologies Co., Ltd. Company Details
Table 158. Nuwacell Biotechnologies Co., Ltd. Business Overview
Table 159. Nuwacell Biotechnologies Co., Ltd. iPSC Cell Therapies Product
Table 160. Nuwacell Biotechnologies Co., Ltd. Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 161. Nuwacell Biotechnologies Co., Ltd. Recent Development
Table 162. ihan Biotech Company Details
Table 163. ihan Biotech Business Overview
Table 164. ihan Biotech iPSC Cell Therapies Product
Table 165. ihan Biotech Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 166. ihan Biotech Recent Development
Table 167. iRegene Company Details
Table 168. iRegene Business Overview
Table 169. iRegene iPSC Cell Therapies Product
Table 170. iRegene Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 171. iRegene Recent Development
Table 172. Allife Medicine Company Details
Table 173. Allife Medicine Business Overview
Table 174. Allife Medicine iPSC Cell Therapies Product
Table 175. Allife Medicine Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 176. Allife Medicine Recent Development
Table 177. CellOrigin Company Details
Table 178. CellOrigin Business Overview
Table 179. CellOrigin iPSC Cell Therapies Product
Table 180. CellOrigin Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 181. CellOrigin Recent Development
Table 182. XellSmart bio Company Details
Table 183. XellSmart bio Business Overview
Table 184. XellSmart bio iPSC Cell Therapies Product
Table 185. XellSmart bio Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 186. XellSmart bio Recent Development
Table 187. ThinkingBioMed Company Details
Table 188. ThinkingBioMed Business Overview
Table 189. ThinkingBioMed iPSC Cell Therapies Product
Table 190. ThinkingBioMed Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 191. ThinkingBioMed Recent Development
Table 192. Cell Inspire Bio Company Details
Table 193. Cell Inspire Bio Business Overview
Table 194. Cell Inspire Bio iPSC Cell Therapies Product
Table 195. Cell Inspire Bio Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 196. Cell Inspire Bio Recent Development
Table 197. Hema Cell Company Details
Table 198. Hema Cell Business Overview
Table 199. Hema Cell iPSC Cell Therapies Product
Table 200. Hema Cell Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 201. Hema Cell Recent Development
Table 202. Yuesai BIO Company Details
Table 203. Yuesai BIO Business Overview
Table 204. Yuesai BIO iPSC Cell Therapies Product
Table 205. Yuesai BIO Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 206. Yuesai BIO Recent Development
Table 207. Cytovia Company Details
Table 208. Cytovia Business Overview
Table 209. Cytovia iPSC Cell Therapies Product
Table 210. Cytovia Revenue in iPSC Cell Therapies Business (US$ Million), 2021–2026
Table 211. Cytovia Recent Development
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
Table 215. Authors List of This Report


List of Figures
Figure 1. iPSC Cell Therapies Picture
Figure 2. Global iPSC Cell Therapies Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global iPSC Cell Therapies Market Share by Type: 2025 vs 2032
Figure 4. Preclinical/Research Stage Features
Figure 5. Clinical Stage Features
Figure 6. Commercial Stage Features
Figure 7. Global iPSC Cell Therapies Market Size by Application (US$ Million), 2021–2032
Figure 8. Global iPSC Cell Therapies Market Share by Application: 2025 vs 2032
Figure 9. Neurodegenerative Diseases Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Diabetes Case Studies
Figure 12. Other Case Studies
Figure 13. iPSC Cell Therapies Report Years Considered
Figure 14. Global iPSC Cell Therapies Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global iPSC Cell Therapies Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global iPSC Cell Therapies Market Share by Region: 2025 vs 2032
Figure 17. Global iPSC Cell Therapies Market Share by Players in 2025
Figure 18. Global iPSC Cell Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by iPSC Cell Therapies Revenue in 2025
Figure 20. North America iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America iPSC Cell Therapies Market Share by Country (2021–2032)
Figure 22. United States iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe iPSC Cell Therapies Market Share by Country (2021–2032)
Figure 26. Germany iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific iPSC Cell Therapies Market Share by Region (2021–2032)
Figure 34. China iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America iPSC Cell Therapies Market Share by Country (2021–2032)
Figure 42. Mexico iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa iPSC Cell Therapies Market Share by Country (2021–2032)
Figure 46. Israel iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE iPSC Cell Therapies Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Bayer(BlueRock Therapeutics) Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 50. Notch Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 51. Evotec Group Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 52. Pluristyx, Inc Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 53. Cellino Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 54. Fate Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 55. Allogene Therapeutics, Inc. Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 56. Takeda Pharmaceutical Company Limited Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 57. Century Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 58. Resolution Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 59. Kenai Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 60. Garuda Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 61. Hebecell Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 62. Allele Biotechnology and Pharmaceuticals Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 63. Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 64. ElevateBio Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 65. iCamumo Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 66. BeiGene, Ltd Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 67. LumiSTAR Biotechnology Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 68. Neukio Biotherapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 69. Help Therapeutics Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 70. Hopstem Biotechnology Inc. Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 71. Nuwacell Biotechnologies Co., Ltd. Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 72. ihan Biotech Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 73. iRegene Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 74. Allife Medicine Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 75. CellOrigin Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 76. XellSmart bio Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 77. ThinkingBioMed Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 78. Cell Inspire Bio Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 79. Hema Cell Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 80. Yuesai BIO Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 81. Cytovia Revenue Growth Rate in iPSC Cell Therapies Business (2021–2026)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed